Access to AusDI requires the user to register a personal account for use with their mobile devices. Users must register using a desktop PC or laptop, not a phone/iPad/tablet.
Please Note: A personal account is not required for desktop access.
Register an AusDI personal account (free)
Use the personal account credentials you created to login to AusDI on your mobile device, or to access the personalised login features on your desktop PC or laptop.
Renewing your account
AusDI requires already registered users to renew their account once a year (before 23 October)
If your account has expired (after 23 October), you will need to recomplete the account registration steps using your Notre Dame email address (see above).
Helpful links
How do I access AusDI off campus or on mobile?
Comprehensive reference of over 500 injectable medicines, including 82 cancer therapies and more than 240 monographs with information about use in infants and children.
Concise, up-to-date source of independent drug information to facilitate effective, rational, safe, and economical prescribing and dispensing recommendations.
Therapeutic Guidelines is an Australian evidence-based resource which recommends therapies for common disorders seen in clinical practice.
The Therapeutic Guidelines (eTG) App is available for online and offline use, ideal for accessing vital information at the point of care.
If your mobile device is connected to University wifi, you will be granted automatic access when you open the Therapeutic Guidelines app.
For off-campus access, see the FAQ How do I access the eTG Therapeutic Guidelines app?
An Australian resource offering Evidence Based Recommended Practices, Systematic Reviews, Consumer Information Sheets, and Systematic Review Protocols.
UpToDate is an evidence-based clinical decision support tool, providing key clinical and drug information at point of care, synthesizing the latest evidence to recommend best practices for thousands of medical conditions.
Copyright © 2025 The University of Notre Dame Australia | CRICOS Provider Code: 01032F | TEQSA PRV12170 | RTO Code 0064